Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech in May: market surveillance movements, reimbursement and fees reimbursement make Clinica’s top 10

This article was originally published in Clinica

Executive Summary

During the month of May, trends in reporting activities by competent authorities captured the most attention from Clinica’s readers. The month’s most-read article reported the surprise downturn in the number of reports exchanged between these EU bodies; given the effort at tighter enforcement and better communication between competent authorities, this was unexpected. But does it suggest that the tougher environment now emerging as a result of the commission medtech immediate joint action plan - launched in 2012 - is actually working and fewer events are occurring?

You may also be interested in...



EU Regulatory Roundup, March 2020: MDR Delay And Unprecedented COVID-19 Measures

Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.

UK Waives Import Taxes On COVID-19 Products

Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies

Belgium Bans COVID-19 Antibody Self-Tests But UK Goes Ahead

While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.

Topics

UsernamePublicRestriction

Register

MT102637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel